Development of cell-based DDS to overcome biological barriers for treating brain diseases

Key Points

• The aim is to explore the development of cell-based drug delivery systems (DDS) that can effectively navigate biological barriers for treating brain diseases.
• Review of recent trends in cell-based DDS for central nervous system disorders.
• Utilization of circulating cells, particularly neutrophils, for DDS development.
• Focus on cell engineering techniques aimed at cancer immunotherapy applications.
• Enhancements in drug delivery efficacy noted through the use of inflammation-responsive cells.
• Positive implications for using neutrophils in drug delivery and cancer treatment.
• Advancements in cell engineering systems to facilitate targeted immunotherapy strategies.

Abstract